Hints and tips:
Related Special Reports
...US drug regulators have delayed a decision on whether to approve Eli Lilly’s breakthrough Alzheimer’s drug, which was expected to be greenlit this month, the drugmaker said on Friday....
...“The FDA has informed Lilly it wants to further understand topics related to evaluating the safety and efficacy of donanemab, including the safety results in donanemab-treated patients and the efficacy implications...
...Brian Costell, a neurologist at First Choice Neurology in Boca Raton, Florida, and is one of the most prolific prescribers of Leqembi, said he did not understand why the FDA was “pushing the brakes” on donanemab...
...Hence, I understand why Asprey and Patil harness diagnostic tools to optimise their lifestyles....
...“What these papers are doing is setting the framework for how you use these ancient human genomes to understand the origin and spread of disease risk.”...
...Clinical trial results have shown the potential of two drugs to slow the progress of Alzheimer’s disease, from Eli Lilly and a partnership between Eisai and Biogen, while Novo Nordisk added to the formidable...
...“There is a distinction between collecting real world evidence to understand more [about the drug] versus mandating reimbursement based on participation in that real world data collection,” Ivan Cheung,...
...It was a book the author began in the 1990s but, suffering from Alzheimer’s, couldn’t ever finish to his satisfaction....
...“We understand [the warning] was attached so that the treatment can be used safely and properly with the understanding of its risks and benefits,” Haruo Naito, Eisai’s chief executive, said at a news conference...
...“My idea was, if we don’t understand the mutation cases, we will never understand the more common forms. You start off with what is simple,” Lannfelt says....
...of the Roche diagnostics business, and is now focusing on improving the future of the pharmaceutical division with internal development and deals, after disappointments including two of its late-stage Alzheimer...
...Some good news New research suggests men prescribed erectile dysfunction drugs are also less likely to develop Alzheimer’s disease years later....
...“I wanted caregivers to understand”, Kiper writes, “that it was not character flaws that made caregiving so fraught, but rather their own brain’s intrinsic workings.”...
...“I don’t think there will be such a controversial debate this time since there is only one Clarity AD clinical trial for lecanemab so it is a very simple and easy to understand drug development.”...
...“We haven’t had enough time to follow through and understand what the implications of Covid are for people who may one day develop dementia,” she says....
...Persevering: Big Pharma had largely given up on the search for an Alzheimer’s drug. A Swedish start-up’s new treatment could receive approval this week....
...Been itching to understand what all the quantum computing hype is about? Check out our new visual guide....
...Just a couple of weeks ago, Eli Lilly released this kind of blockbuster drug that was shown to slow the development of Alzheimer’s....
...“I’ve played in the crypto market, I don’t understand it, I still don’t understand it.” he said. “Believe it or not, I made money and I still don’t know how I made money in crypto....
...We don’t yet fully understand how they work and cannot demonstrate likely outcomes in advance....
...Researchers led by Chan are using MRI scans to understand the causes of Covid’s effects on memory, thinking speed and decision making....
...I can understand this urge — when my father died from Alzheimer’s in 2015, my siblings and I found ourselves thinking about him in earlier years, having suppressed those memories because we wanted to love...
...In the long run, Roche hopes to create a model of Alzheimer’s disease and all the key cell types that are involved in immune regulation in cancer....
...It is shocking, inspiring, moving, funny — and mesmerising if you want to understand America today....
...For example, taking this approach to making a difference in the challenges of Alzheimer’s disease ultimately led to identifying the only known scientist with a protocol to reverse cognitive decline in Alzheimer...
International Edition